Intended for healthcare professionals

Letter

“Polypill” to fight cardiovascular disease: Cost effectiveness of statins for primary prevention of cardiovascular events is questionable

BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7418.808-c (Published 02 October 2003) Cite this as: BMJ 2003;327:808